IndiaDescription
Manufacturer of active pharmaceutical ingredients renamed in January 2025 from Glenmark Life Sciences. Portfolio of around 170 APIs in chronic therapies: cardiovascular, central nervous system, oncology, pain and diabetes. Four plants — Ankleshwar and Dahej in Gujarat, Mohol and Kurkumbh in Maharashtra — with more than 900 tonnes of annual capacity. States supply to over 700 pharmaceutical companies worldwide.